Levels of NOS2 transcripts were also significantly higher in DLX4-High tumors than in DLX4-Low tumors (P = 0.021) in an independent patient cohort (n = 260 cases) from the Japanese Serous Ovarian Cancer Group Study [24]. This evidence concerns the gene DLX4 and ovarian carcinoma.